Cargando…

Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study

BACKGROUND: There are few effective tools to predict survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas. AIM: To develop comprehensive nomograms to individually estimate the survival outcome of patients with invasive intraductal papillary mucinous neoplasms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jia-Yuan, Wang, Yu-Feng, Ma, Huan, Li, Sha-Sha, Miao, Hui-Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015718/
https://www.ncbi.nlm.nih.gov/pubmed/32089629
http://dx.doi.org/10.3748/wjg.v26.i5.535
_version_ 1783496851163447296
author Wu, Jia-Yuan
Wang, Yu-Feng
Ma, Huan
Li, Sha-Sha
Miao, Hui-Lai
author_facet Wu, Jia-Yuan
Wang, Yu-Feng
Ma, Huan
Li, Sha-Sha
Miao, Hui-Lai
author_sort Wu, Jia-Yuan
collection PubMed
description BACKGROUND: There are few effective tools to predict survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas. AIM: To develop comprehensive nomograms to individually estimate the survival outcome of patients with invasive intraductal papillary mucinous neoplasms of the pancreas. METHODS: Data of 1219 patients with invasive intraductal papillary mucinous neoplasms after resection were extracted from the Surveillance, Epidemiology, and End Results database, and randomly divided into the training (n = 853) and the validation (n = 366) cohorts. Based on the Cox regression model, nomograms were constructed to predict overall survival and cancer-specific survival for an individual patient. The performance of the nomograms was measured according to discrimination, calibration, and clinical utility. Moreover, we compared the predictive accuracy of the nomograms with that of the traditional staging system. RESULTS: In the training cohort, age, marital status, histological type, T stage, N stage, M stage, and chemotherapy were selected to construct nomograms. Compared with the American Joint Committee on Cancer 7(th) staging system, the nomograms were generally more discriminative. The nomograms passed the calibration steps by showing high consistency between actual probability and nomogram prediction. Categorial net classification improvements and integrated discrimination improvements suggested that the predictive accuracy of the nomograms exceeded that of the American Joint Committee on Cancer staging system. With respect to decision curve analyses, the nomograms exhibited more preferable net benefit gains than the staging system across a wide range of threshold probabilities. CONCLUSION: The nomograms show improved predictive accuracy, discrimination capability, and clinical utility, which can be used as reliable tools for risk classification and treatment recommendations.
format Online
Article
Text
id pubmed-7015718
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-70157182020-02-21 Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study Wu, Jia-Yuan Wang, Yu-Feng Ma, Huan Li, Sha-Sha Miao, Hui-Lai World J Gastroenterol Retrospective Study BACKGROUND: There are few effective tools to predict survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas. AIM: To develop comprehensive nomograms to individually estimate the survival outcome of patients with invasive intraductal papillary mucinous neoplasms of the pancreas. METHODS: Data of 1219 patients with invasive intraductal papillary mucinous neoplasms after resection were extracted from the Surveillance, Epidemiology, and End Results database, and randomly divided into the training (n = 853) and the validation (n = 366) cohorts. Based on the Cox regression model, nomograms were constructed to predict overall survival and cancer-specific survival for an individual patient. The performance of the nomograms was measured according to discrimination, calibration, and clinical utility. Moreover, we compared the predictive accuracy of the nomograms with that of the traditional staging system. RESULTS: In the training cohort, age, marital status, histological type, T stage, N stage, M stage, and chemotherapy were selected to construct nomograms. Compared with the American Joint Committee on Cancer 7(th) staging system, the nomograms were generally more discriminative. The nomograms passed the calibration steps by showing high consistency between actual probability and nomogram prediction. Categorial net classification improvements and integrated discrimination improvements suggested that the predictive accuracy of the nomograms exceeded that of the American Joint Committee on Cancer staging system. With respect to decision curve analyses, the nomograms exhibited more preferable net benefit gains than the staging system across a wide range of threshold probabilities. CONCLUSION: The nomograms show improved predictive accuracy, discrimination capability, and clinical utility, which can be used as reliable tools for risk classification and treatment recommendations. Baishideng Publishing Group Inc 2020-02-07 2020-02-07 /pmc/articles/PMC7015718/ /pubmed/32089629 http://dx.doi.org/10.3748/wjg.v26.i5.535 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Wu, Jia-Yuan
Wang, Yu-Feng
Ma, Huan
Li, Sha-Sha
Miao, Hui-Lai
Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title_full Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title_fullStr Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title_full_unstemmed Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title_short Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study
title_sort nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: a population-based study
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015718/
https://www.ncbi.nlm.nih.gov/pubmed/32089629
http://dx.doi.org/10.3748/wjg.v26.i5.535
work_keys_str_mv AT wujiayuan nomogramspredictinglongtermsurvivalinpatientswithinvasiveintraductalpapillarymucinousneoplasmsofthepancreasapopulationbasedstudy
AT wangyufeng nomogramspredictinglongtermsurvivalinpatientswithinvasiveintraductalpapillarymucinousneoplasmsofthepancreasapopulationbasedstudy
AT mahuan nomogramspredictinglongtermsurvivalinpatientswithinvasiveintraductalpapillarymucinousneoplasmsofthepancreasapopulationbasedstudy
AT lishasha nomogramspredictinglongtermsurvivalinpatientswithinvasiveintraductalpapillarymucinousneoplasmsofthepancreasapopulationbasedstudy
AT miaohuilai nomogramspredictinglongtermsurvivalinpatientswithinvasiveintraductalpapillarymucinousneoplasmsofthepancreasapopulationbasedstudy